ACVR1B and breast cancer: Among these, only ETS1 showed a strong negative correlation with ACVR1B and a positive correlation with MGAT5 in TCGA pancreatic and breast cancer cohorts (Fig. 8a–c), implicating ETS1 in ALK4 loss-mediated MGAT5 upregulation.